Research ArticleOriginal Research
A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects
Michael D Davis, Tatiana M Clemente, Olivia K Giddings, Kristie Ross, Rebekah S Cunningham, Laura Smith, Edward Simpson, Yunlong Liu, Kirsten Kloepfer, I Scott Ramsey, Yi Zhao, Christopher M Robinson, Stacey D Gilk and Benjamin Gaston
Respiratory Care January 2021, 66 (1) 113-119; DOI: https://doi.org/10.4187/respcare.08425
Michael D Davis
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine.
Division of Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indianapolis, Indiana.
Tatiana M Clemente
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
Olivia K Giddings
Department of Pediatrics, Case Western Reserve University School of Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Kristie Ross
Department of Pediatrics, Case Western Reserve University School of Medicine, Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Rebekah S Cunningham
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine.
Laura Smith
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine.
Edward Simpson
Center for Computational Biology and Informatics, Indiana University School of Medicine, Indianapolis, Indiana.
Department of BioHealth Informatics, School of Informatics and Computing, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana.
Yunlong Liu
Center for Computational Biology and Informatics, Indiana University School of Medicine, Indianapolis, Indiana.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana.
Kirsten Kloepfer
Division of Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indianapolis, Indiana.
I Scott Ramsey
Department of Physiology and Biophysics, Virginia Commonwealth University, Richmond, Virginia.
Yi Zhao
Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana.
Christopher M Robinson
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
Stacey D Gilk
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana.
Benjamin Gaston
Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine.
Division of Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children, Indianapolis, Indiana.
In this issue
Respiratory Care
Vol. 66, Issue 1
1 Jan 2021
A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects
Michael D Davis, Tatiana M Clemente, Olivia K Giddings, Kristie Ross, Rebekah S Cunningham, Laura Smith, Edward Simpson, Yunlong Liu, Kirsten Kloepfer, I Scott Ramsey, Yi Zhao, Christopher M Robinson, Stacey D Gilk, Benjamin Gaston
Respiratory Care Jan 2021, 66 (1) 113-119; DOI: 10.4187/respcare.08425
A Treatment to Eliminate SARS-CoV-2 Replication in Human Airway Epithelial Cells Is Safe for Inhalation as an Aerosol in Healthy Human Subjects
Michael D Davis, Tatiana M Clemente, Olivia K Giddings, Kristie Ross, Rebekah S Cunningham, Laura Smith, Edward Simpson, Yunlong Liu, Kirsten Kloepfer, I Scott Ramsey, Yi Zhao, Christopher M Robinson, Stacey D Gilk, Benjamin Gaston
Respiratory Care Jan 2021, 66 (1) 113-119; DOI: 10.4187/respcare.08425